Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
44
AMED Quote, Financials, Valuation and Earnings
Last price:
$91.50
Seasonality move
:
7.62%
Day range:
$91.13 - $92.46
52-week range:
$82.15 - $98.95
Dividend yield:
0%
P/E ratio:
69.86x
P/S ratio:
1.29x
P/B ratio:
2.65x
Volume:
302.9K
Avg. volume:
321.1K
1-year change:
-0.82%
Market cap:
$3B
Revenue:
$2.3B
EPS (TTM):
$1.31
Earnings Data
Next earnings date for AMED
Apr 24
2025
Most recent earnings per share
-$0.62
Missed by $1.68
(Feb 26/2025)
Consensus Estimate
$1.06
(Feb 26/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AMED Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $611.6M | -- | -- | $1.37 | -- |
| 04/24/2025 | Q1 | $595.8M | -- | -- | $1.12 | -- |
| 02/26/2025 | Q4 | $602.4M | $598.1M | -$0.62 | $1.06 | -$1.68 |
| 11/06/2024 | Q3 | $588.8M | $587.7M | $0.51 | $1.17 | -$0.66 |
| 07/24/2024 | Q2 | $581.8M | $591.2M | $0.98 | $1.18 | -$0.20 |
| 05/03/2024 | Q1 | $569.3M | $571.4M | $0.44 | $1.01 | -$0.57 |
| 02/16/2024 | Q4 | $567.7M | $570.8M | $0.59 | $1.03 | -$0.44 |
| 10/24/2023 | Q3 | -- | -- | $0.79 | $1.07 | -$0.28 |
| 07/26/2023 | Q2 | -- | -- | -$2.46 | $1.09 | -$3.55 |
| 05/03/2023 | Q1 | -- | -- | $0.77 | $0.88 | -$0.11 |
| 02/15/2023 | Q4 | -- | -- | $0.97 | $0.98 | -$0.01 |
| 10/26/2022 | Q3 | -- | -- | $0.79 | $1.22 | -$0.43 |
| 07/27/2022 | Q2 | -- | -- | $0.91 | $1.23 | -$0.32 |
| 04/27/2022 | Q1 | -- | -- | $0.97 | $1.12 | -$0.15 |
| 02/23/2022 | Q4 | -- | -- | $1.04 | $1.18 | -$0.14 |
| 11/02/2021 | Q3 | -- | -- | $1.37 | $1.37 | $0.00 |
| 08/04/2021 | Q2 | -- | -- | $2.43 | $1.67 | $0.76 |
| 04/28/2021 | Q1 | -- | -- | $1.50 | -- | -- |
| 02/25/2021 | Q4 | -- | -- | $1.36 | -- | -- |
| 10/28/2020 | Q3 | -- | -- | $2.16 | -- | -- |
| 07/28/2020 | Q2 | -- | -- | $1.04 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | $0.96 | -- | -- |
| 02/18/2020 | Q4 | -- | -- | $0.83 | -- | -- |
| 10/29/2019 | Q3 | -- | -- | $1.03 | -- | -- |
| 07/31/2019 | Q2 | -- | -- | $1.02 | -- | -- |
| 04/30/2019 | Q1 | -- | -- | $0.95 | -- | -- |
| 02/27/2019 | Q4 | -- | -- | $0.84 | -- | -- |
| 10/29/2018 | Q3 | -- | -- | $0.96 | -- | -- |
| 07/31/2018 | Q2 | -- | -- | $0.98 | -- | -- |
| 05/07/2018 | Q1 | -- | -- | $0.79 | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -$0.11 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | $0.42 | -- | -- |
| 07/26/2017 | Q2 | -- | -- | $0.13 | -- | -- |
| 05/02/2017 | Q1 | -- | -- | $0.44 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | $0.26 | -- | -- |
| 11/04/2016 | Q3 | -- | -- | $0.34 | -- | -- |
| 08/02/2016 | Q2 | -- | -- | $0.32 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | $0.19 | -- | -- |
| 03/09/2016 | Q4 | -- | -- | $0.38 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | $0.25 | -- | -- |
| 07/29/2015 | Q2 | -- | -- | $0.32 | -- | -- |
Amedisys Earnings Questions
-
How Much did Amedisys Generate in Revenue Last Quarter?
Amedisys reported $598.1M worth of top line sales in its most recent quarter.
-
Did Amedisys Beat Earnings Last Quarter?
Amedisys announced earnings per share of -$0.62 which represents a miss of analyst forecast a $1.06 per share.
-
Is Amedisys Profitable?
Amedisys reported $253.4M that represents $7.65 per share over the last quarter.
-
What is the Analyst Consensus for Amedisys EPS Next Year?
Amedisys's earnings are forecast to grow from $1.31 per share to $4.39 per share next year representing an increase of 263.68%.
-
When is Amedisys's Earnings Date?
Amedisys's next earnings date is April 24, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
